eli lilly shares were up over a dollar at nearly $52 at tuesday's close. in the latest ranking of popular brand names, usa today and intrabrand report coca-cola still reigns as the most valuable brand in the world. apple is a close second. its brand worth is up 129% and it may top coke next year. brand values for amazon, samsung and oracle have grown 20% since last year. automakers are up 12%, while goldman sachs lost 16% and blackberry dropped by 40%. walmart stores are stepping up sales efforts and getting into same-day delivery. walmart is testing its "walmart to go" services to compete with amazon, which recently launched a same-day delivery service. the store plans to deliver same-day service for toys, televisions, and any online merchandise, just in time for the holidays. meanwhile, over at sears, sears hometown will reportedly start trading on the nasdaq on friday. it is a spinoff of sears holdings. the retailer is splitting off companies in an effort to boost its profits. some corporations are putting the brakes on business travel. a survey by the

2550 and a global specialist tdd#: 1-800-345-2550 will help you get started today. >>> shares of eli lillyrading lower today. down 2.5% right now. the pharmaceutical company reporting a 7% increase in profit but as we've heard from so many companies lately, revenue came in light. they were down 11% for lilly. but with one big drug having lost patent protection, can lilly count on their experimental alzheimer's drug and other drugs in the pipeline to fill the sales void? >> joining us now is the chairman and ceo of eli lilly. welcome back to cnbc. great to see you. >> thanks, maria. it's great to see you. we have a lot of exciting stuff going on. >> let's talk about that. i guess the earnings story is certainly what investors are focused on right now. you have talked about currency being an issue and the removal of your insulin business from cvs caremark as one of the reasons for the shortfall bill was just talking about. is there anything else that played as big a role there? we're trying to get a sense of what's going on for the corporate sector right now. >> insulin sales were a little s

i like eli lilly and merck. eli lilly came up with a potential alzheimer's drug. these are good baby boomer type place. they don't like to play individual like these. i like stocks up with decent dividends but you don't like the individual health care. there are ways to play with funds. these big pharma stocks in there, and medical device companies. you want to go down there, you can do the fun route but i like eli lilly and merck. liz: all pharmaceutical plays have different views. to look at those two and say they play on aging population that is now living a lot longer to those of the two names you like there. we also show consumer names, there are concerns consumer names could get hurt. >> these are necessities, not luxuries. even if we see a downturn and another double dip for whatever you want to call it, you eat breakfast, you use shampoo. my shampoo budget is pretty low, but these are things that we use everyday. liz: and everybody is mainlining diet coke around here. >> we like general mills and coke right now. it also have to consider some of these compa

eli lilly getting a bump of about 5.5%. markets, not so much. bump here on this day where the bond market is closed, but equities still moving, and we are on the cusp of earnings season. let's get over to david asman. david: so much anticipation about earnings. you go to any of these internet sites and see a lot of anticipation. some people fearing the worst, a lot of these earnings may turn out to be losses, even so far as alcoa which kicks it off tomorrow, but it's going to be a very busy week. liz: we'll see tomorrow exactly at in this time. let's go to nicole on the floor of the new york stock exchange. the dow kind of gained some ground in the last half hour of trading. >> reporter: a little bit, but i have to tell you, i think traders not putting too much to one way or the other in this market today. it's the columbus day holiday, a move about a tenth of a percent, and last week we gained 1.2%. david: but, you know, there are some sneakers in there, people are sneaking up despite the low volume, and one is netflix. huge jump in netflix tod

that's why all eyes have been on eli lilly since reporting top line results back in august. shares of lilly have been rallying nearly 13 where is, shares higher or not news. back to you. >> thank you, seema. very important development there. >>> it is a down day for the markets but walmart and auto nation are hitting new highs today. a ton of stocks from a number of sectors have hit all-time highs in this market over the past few weeks. disney, discovery communications, our parent company comcast among the names in the media world. julia boorstin is taking a closer look at these high-flying plays. >> well, bob, content remains king and people are not cutting the cord. the big question for media stocks is whether they can keep on growing. disney is at all-time highs, up 65% just in the past year. today disdisney was downgraded to average questioned whether it can maintain its pace. despite the news hacking scandal, news corp. is also on a tear on both ad and cable trends, up levels we haven't seen since 2007. discovery and scripps network interactive are also hitting highs we

drug maker eli lilly is planning a multimillion dollar expansion of its manufacturing operations in indianapolis to make card trijs that deliver -- cartridges that deliver insulin to diabetes. it's a disease that affects nearly 26 million americans. u.s. newspaper circulation was flat from april through september. a media industry group says "the wall street journal" kept its position as the number one newspaper. "u.s.a. today" was second. "the new york times" was third. that's your money watch. for more go to cbsmoneywatch.com. in new york, i'm lex leg. >>> seems like -- i'm alexis christoforous. >>> seems like forever but we're now a few days away from election 2012. >> the presidential campaign will be back in full gear today. 9news now returns in two minutes. stay with us. [ harry umlaut ] here we go. [ sally umlaut ] what? the five stages of muller. ah yes... stage one: suspicion. "it's a yogurt, how good can it be?" stage two: revision. "actually, this ain't bad." stage three: surprise! "look at this cool cornery thing! i love this stuff!!" stage four: desolation. "it's gone!" stage five:

a lot of this has to do with eli lilly. $2.03 jumping higher on positive news about a chance that had positive results, we always like to see this because it gives help for patients but also for shareholders a very good day, and a great day for stocks. we jumped through the earlier high of the session up 100 points for the dow jones industrials. look at the s&p on our little ticker above the 1400, it is a nice day for all stocks, let's go over to ashley webster in for david asman. ashley: thank you. i like your handkerchiefs. how about the financials in the last hour who loved america. i don't know if the bar is being set so low everybody can walk over it but citigroup is pretty good. jpmorgan pretty good, so the financials are looking good. liz: we don't have to wait for nicole petallides, there on the new york stock exchange. confirmation of a story that roque friday, sprint is turning japanese. nicole: that is right, actually hire most of the day, drink the red late in the day, but that is right. acquiring 70% of sprint. the largest deal of its kind, coming in for american company.

nickel, eli lilly shares at a four year high. where are they now.e: i love you are absolutely right. so many analysts jumping on board for their price targets and most have price targets under $50 and it was $52 a we're seeing now 5220 the highest levels since 2008 and this is all on a drug for alzheimer's that had some great findings and experimental drugs that lead to reduction in the morelos so 34% reduction in memory loss and that is some good news. charles: great news for everybody watching. sticking with the medical team. 13,000 people in 23 u.s. states received steroid injections links to rare fumble meningitis outbreak. eight of those people have died. 105 cases have been confirmed in nine states. joining the company is dr. mark siegel with the fox medical ateam. where are we? is it contained? where are we with this outbreak? >> i don't want people to be scared. meningitis is an infection of the lining of the brain. this is a fungus. usually it floats around the air in the dirt and soil. you don't get sick from it. in this case it has been f

so this is wonderful news for eli lilly. the stock is up 4%.y will be testing it not only for gastric cancer but also other cancers which could boost the sales even more which are already anticipated to be 600 million dollars in annual sales. this is great news in obviously the war on cancer and great news for eli lilly. it is up today. back to you. ashley: nicole thank you very much. spain's credit rating is just above junk status. what will happen if it falls below that? can it be avoided anyway? we investigate next. >> as we head to break, let's take a look at winners and losers on s&p 500. the dow is drifting a little lower here. it had been up as much as 100 points, but there are some outperformers nonetheless. sandisk being one of them up 3% at the moment. we are back with markets now after this. ashley: here's a question, will moody's cut spain's credit rating to junk status? that's what investors are waiting to find out this month. my next guest says a downgrade by that ratings agency could spark a sell off in spanish bonds. joining me

. >> caller: my stocks are conoco-philips, at&t, energy transfer partners, etp, eli lilly, lly and bankica, bc. >> let me go to work on this. eli lily, i would not sell. at&t, people suddenly like verizon more, i would not sell it, good yield, conoco-philips, nat gas comes back, they're a huge producer. bank of america, no thank you, it's a lawsuit-o-rama there. i want you to own wells fargo. why, they're buying back stock and warren buffett bought $1 billion in the last week. energy transfer partners, this is a company where the ceo will belong on the wall of shame if they do an equity offering down here. we've got an oil and gas play, we've got eli lilly, and let's buy some general electric because the stock is down and i think it should be bought. my charitable trust continues to buy it. ted in connecticut, please, ted? >> caller: hey, jim, good afternoon. >> good afternoon to you. >> caller: i'd like to know if i'm diversified. >> okay. >> caller: my stocks are boeing, b.a., american capital agency, agnc, accenture, acn, apple, aapl, and energy transfer partners, etp. >> okay. all r

eli lilly has gotten some positive results for a stomach cancer drug.ole, what's the story here and the stock, please. >> i'm going to tell you a story, another advancement on the war in cancer, in in case we're watching eli lilly. the stock is jumping on the latest clinical trials, the experimental trials that they have bean doing, moving into the late stages of their goal and it's really doing well. it's up 31/2%. this is for gastric cancer, it's a drug that basically improves overall survival. the name of the drug, should bring in isi says 600 million in the drugs in gastric cancer alone. stuart, this could boost sales farther. it's being tested in other tumor types as well and so we'll see what happens, whether those tests are positive, but the long and short of it is that it improves overall survival. stuart: you know, we like to see a stock go up and we love to hear stories about something bringing in a lot of money, but the best news of all is that the potential to ensure us an about thor life for those people who have this ailment, this conditio

abbott and eli lilly started their moves from about 4% when you were getting almost nothing from the tech stocks. even after the runs they continue with better yields either because they keep raising their dividends like lilly, or they bring out value like abbott is doing because it's splitting into two separate companies. i don't want to be part of the cabal that plays up to the doom and gloom stories. even abbott, even as their relationship with the fiscal cliff is chimerical at best, the nokias, the research in motions, without having some these is of genuine progress or real innovation. i would rather have you in something cheap like the banks and the retailers with good dividends and real opportunities like the drug stocks, yes, even after this move. here is the bottom line. we're too much like that old man in "north by northwest" who tells cary grant that a suspicious aircraft was dusting crops where there ain't no crops. we're looking for breakthroughs where there ain't no breakthroughs. and we're looking for cliffs where there ain't no cliffs. it's time to start focusing on wh

. >>> experimental drug paid by eli lilly is showing hope for people with early stage alzheimer's. there is concern about the long term benefit of the drug. researchers say it may not be enough to win approval from the fda. they say it shows they are on the right track. >>> the overall u.s. economy may be weak but where the beer index is concerned, we are the super power to beat. the beer index is the amount of time you have to spend on-the-job to afford to buy a beer. swiss bank surveyed hourly wages and average prices at liquor stores in 150 countries and found u.s. workers only need five minutes earnings to buy a beer. that equals 96 beers per eight hour workday or 480 beers on an average workweek. it takes the rest of the world 20 minutes to earn a beer. either we are very thirsty or we earn more than the rest of the world. >>> a lot of that hard work will be going down the drain with the a's game tonight, i'm sure -- >> i didn't know where you were going. >> yeah. next, we continue to follow breaking news in the east bay where fire crews are watching for flare-ups from a huge

eli lilly, what a fantastic stock. we recommended it a while ago.t woke up to the idea it's good. hp, one of the worst stocks i've ever seen, but it's a technology play. heckmann. an oil service play. and telco, technology but involving finance, real technology and drug. technology, drug, finance, oil, tech, a telco. ♪ hallelujah >> that was easy. >> janet in my home state of new jersey. >> caller: hi, jim. my brother and i watch you all the time. >> thank you. >> caller: a good boo-yah to you. my stocks are eaton, etn, verizon, vz, mcdonald's, mcd, state street, stt, deere, de. am i diversified? >> a wild performer. we have interesting. eaton, a charitable trust name. a core position for action alerts for years. state streets finance. mcdonald's, deere, terrific product. not a well-run company, unfortunately. and verizon telco. we have telco, farm equipment we have restaurant, we have diversified manufacturing, and we have financial. again, picture-perfect it's got yield, yield, yield. not bad. boy, our players really were good tonight. ♪ halleluja

eli lilly up 4% after goldman upgrades the drug maker to neutral from sell. the company known for remmington and other consumer brands is buying stanley black & decker's hardware for $1.4 million. >>> the imf global economy risks skidding back into the recession three short years from emerging from the previous one, this is ahead of the earnings kickoff tonight. we are joined by our friend here, good to see you, and today is the five-year anniversary of the record high. people like to make comparisons where we are now. david in the first hour of "squawk on the street" said this is a little freaky because at that time we were hitting highs and we didn't know what was going to hit us in the months to come. and here we are sitting at our highs for this run-up and maybe we don't know what's going to hit us in the months to come. >> well, that's a function of the business, okay? if we knew exactly what was out there we'd come in, set the price in the morning and go swimming. you know, you've got to stand and pay attention, not only day by day, but minute by minute

we get data on manufacturing, new home sales and earnings from att, boeing, eli lilly, delta and us airways. the dow dropping 243 points yesterday to close at 13102. the nasdaq losing 26 to close at 2990. facebook stock rose more than 14% in after hours trading last night on the back of the company's positive earnings. revenue rising 32%. slightly better than expected. the social networking giant may have figured out how to make money from people shifting from pcs to mobile devices. facebook made $153 million from the sale of mobile ads. that's a category that didn't even exist for the company sev months ago. ceo zuckerberg saying facebook could eventually make more money from mobile versus desk top adds. nzinga is cutting 5% of its workforce. the first ever round of layoffs for the struggling gamemaker. the company will retire 13 older games and reduce its investment in the game the billy. zynga could shut down studios in the uk and japan. zynga makes 5 of the top 10 games featured on facebook. >> it's your turn on "words with friends," thanks. >> all right. i got to give it to hampton. he

over in the healthcare world, shares of eli lilly gained on word the drugmaker's experimental stomach cancer treatment may improve survival rates. and, the stock has been on tear, rising to a new 4.5 year high. today, it jumped 4% to $52.53 shares of abbott labs also rose on reports nearly all of the patients treated with the company's oral hepatitis-c drug have be cured in midstage trials. that encouraging news lifted the stock 4%., pushing it to an all- time high of 72 and change. meanwhile, amazon.com is reportedly in advanced talks to buy the mobile chip unit of texas instruments. analysts believe a deal would strengthen amazon's supply chain and allow it to more efficiently compete against rivals apple and samsung. there is no word yet on a price. but, shares of texas instruments rose 3% today to a nearly two- month high. amazon shares ended up has well, gaining a little less than 1%. speaking of apple, the stock got a bit of its shine back today, after recently losing nearly 10%. the widely held company added $5 a share to close at just under $635. last month, apple sparkled to

but drug maker eli lilly jumped to a post-recession high, up 5.3% in heavy trading. new data on an experimental alzheimer's drug showed it slowed memory loss in one group of patients. this same drug had disappointing results in earlier trials. all five of the most actively traded exchange traded products were down. the emerging markets and nasdaq one hundred funds fell the most 0.9%. and that's tonight's "market focus." >> tom: the rumor mill and hype machine are running again around apple. this time over what's been called the ipad mini, even though apple won't confirm any details, including the device's name. whatever it's called, it's widely expected to be introduced later this month as a smaller tablet, to better compete on price against google's and amazon's devices. usually a new apple product brings focus on companies providing the parts, but tonight's word on the street is: content. james rogers is with us. james, what does an apple product launch mean for content companies? >> well, it's interesting. typically when apple launches a new product a lot of the a

drugs are appropriate well first the whole idea of the bio chemical imbalance was made up inside eli lilly when they were getting ready to promote prozac even before was approved by the f.d.a. they were sending around doctors to talk about bio chemical imbalance so that that's of that's just pure nonsense. you know whether the drugs have an appropriate place in my practice i find that i can deal with situations without the use of psychiatric drugs i think it's a choice for people provided they have an idea about the risks associated with them and the drugs i was just talking to you without can cause suicide to people need to know that well and and in fact you know let's talk about that a little bit the black labeling of some of these drugs particular the s s r i's my understanding is that. people people come in and they say you know the world is too intense and so ok here's a drug that dials down the world what that drug does is it diminishes their ability to experience their own emotions they're also not so much experiencing other people's emotions and at that point other people cease to

eli lilly? nicole: highest level since 08.e're talking about an experimental alzheimer's drug which did well for eli lilly so far in the experiment. let's take a look here, up 1/2% -- up 3 1/2%. experimental drug for alzheimer's. led to 34% reduction in memory decline for patients with mild symptoms over a period of 18 months. that's a pretty good showing. that's why we saw the stock jumping. speaking of jumping, i wanted to also take a look at some names that have hit some 52 week highs today. i know some of them have pulled back and you may see some red arrows here, but you can't deny that they today hit 52 week highs, in some cases multiyear highs and may be pulling back just a little bit, but still some very monumental levels. back to you. dagen: thank you very much nicole. breaking news right now. europe's markets are closing. if you take a look at england, germany, and france, all three of those markets closing down, but all less than 1% losses there. with the currency market showing the euro extending its losses against

. >>> experimental drug made by eli lilly showing hope for people with early stage alzheimer's.h finds the drug helps slow memory loss and cognitive decline by 30%. concern about the long term benefit of the drug. researchers say it may not be enough to win approval from the fda. they say it shows they are the on the right track in finding treatments to clear the sticky deposits that clog brains. >>> overall u.s. economy may be weak but where the beer index is concerned, we are still the super power. the beer index is the amount of time you have to spend on-the-job to afford a brew. swiss bank surveyed hourly wages and prices at liquor stores in 150 countries and found that u.s. workers only need five minutes of earnings to buy a beer. or 96 beers per eight hour workday or 480 beers over 40 hours. on average, it takes the rest of the world 20 minutes to earn a beer either we are well paid or real thirst day. >> now we need to do the latte index. >>> [ unintelligible ] next complete list of models affected. >>> huge flames rip through a union city strip mall. firefighters had n

bank of montreal, something you think is a money maker, eli lilly and cs holdings. they got one that tells the consumer is doing okay and the economy might recover in some way shape or form. >> that is a good point. i will start with a major leader in health care insurance, and its future depends on the outcome of the election a few weeks away or less. positions for either direction. is a major issue in 2013 in one way or another companies like united health care are prepared to absorb the increase in the policyholders, people who don't have insurance yet, or go another direction in a position to perhaps narrow their margins and that is why we'd like to value with that story but being prepared for the future story. ashley: are very bullish with stocks come a savings could derail the market rally but what sectors do you like in particular? >> as a macro player, we are not playing this extra space, so i firmly believe the trend is in place if we continue to hold these technical levels. ashley: what could derail the market right now, what makes you most concerned at th

we're keeping an eye on drug stocks in particular, eli lilly. this is as they came out with findings on a trial drug they have been working on meeting the late stage goals that they have had for gastric cancer. it's coming out really nicely and just showing survival rates improving and now they may test it for other cancers as well. it is up 4 1/4% right now. back to you. cheryl: thank you very much nicole. the national association of business economists predicting that congress will avoid the fiscal cliff, and that the economy will continue to grow at slightly faster rate in 2013 with gdp rising by 2.4% next year. chief investment officer hank smith is joining me now. do you agree with the nab on all the key points here but still 2% plus gdp next year that does not make much of a recovery? >> well, no, but you have to remember, i mean the biggest macro headwind is that we're still deleveraging and that process still has three to four more years to play out. the good news it's becoming less of a headwind each year. and with respect to the fiscal

looking at eli lilly and bristol-myers squibb coming in with results that put pressure on stocks. both missed analyst estimates top and bottom line misses. eli lilly is being hurt by the diabetes drug not doing well the both companies under pressure with news we heard from the two of them. back to you. lori: nicole, thank you as always. talk about fixed income. the "wall street journal" reporting pimco founder bill gross, the manager of the world's biggest bond fund is pulling back from investments in government debt. joining us to talk about that, the fed decision coming up this afternoon and all things related to fixed income, head of strategy at rbs. hopefully we get that for you. the rally is running on tired and faded legs. bill, great to see you. what is your take? >> lori, you know i have great empathy for what bill gross mentioned this morning. at the same time i've been all around this country talking to major fixed income investors and i hear the same refrain. as we get closer to the election on november 6, with tightening national polls, fixed income investors are becom

pfizer, eli lilly, community health systems.a day where you see the downtown, you do have some names hitting some new highs. they are in the drug related sector. the bank index as well. the retailers are lower. some of these drugs stocks are showing some resilience. back to you. liz: general motors. it surely is interesting. the guy who shorted lehman brothers. david einhorn was that guy. he hammered them right into the ground. let me get you republican senator chuck grassley. demanding geithner come clean about the libor and all. the senate are calling on regulators to create a new "american based index to replace the london bank offer rate." you name it, and a lot of people look at libor and base their interest rates on that. charles gasparino. charles: kind of an interesting low in this whole libor investigation. closed the dismissal of bob diamond. one of the principal players. remember how libor is created. it is a bunch of banks submitting what they think libor should be in a kind of blended together. that becomes the inte

we have got major players reporting next week, apple, caterpillar, at&t, eli lilly, yahoo!, boeing.just to name a few. david: one. up credible things when you looked what happened to this market over the past 24 hours you see a stock like apple dropping 3.6%. huge drop. mcdonald's dropping 4 1/2%. that is the biggest drop for mcdonald's in three years. so, on thursday analysts are expecting the world's most valuable company apple to report their earnings, anything can happen. they may be coming out with the minutey ipad at that conference. be very interesting. actually it is tuesday is the announcement. liz: money with tra melissa francis is next. have a lovely evening. thanks for joining us. melissa: i'm melissa francis and here's what's "money" tonight. the cyber attacks on banks keep coming. now they're taking a menacing turn, striking at random and without warning. we're going to show you how they set them up and how dangerous they could become. plus can you feel it? pain at the pump eases for the 11th straight day. we have details whether the gas price relief will last. >>> wou

shares of eli lilly lept more than 4%. the drugmaker says the late-stage study of its new stomach cancer drug improved patients chances of survival. >>> investors are punishing shares of bankrate after-hours theinancial services company slashed its third quarter and full-year earnings outlook. >>> to our top story tonight according to new reports iran is planning a huge oil spill in the straight of harm muds in the persian gulf. german newspaper is reporting that the plan is code named, murky waters and beingonsidered specifically to block the strait and t 17 million barrels of oil that passes through each day. i was just in the persian gulf lastmont in this very region reporting on exactly how the strait is protected and what would happen if iran tried t do something similar to this,locking ship's routes to international oil tankers. alot like this would create a mess in many ways. but is it realistic? wi me isthe vp of foreign and dfense studies at the aei. thanks so much for coming back to the show. i want to ask you ri

and while the eli lilly drug is not a cure, researchers say it is the first time that any treatment hastients. >>> the mexican navy says it has captured a drug gang commander accused of new jersey rows high-profile crimes, including the possible murder of american tourist david hartley. it was two years ago when tiffany hartley last saw her husband david. they had gone jetskiing on a lake that borders mexico when david was shot and killed. >> i was going back two years ago and feeling the same emotions and wondering is this going to be -- is this going to be it? am i finally going to get what i've been looking for? >> reporter: tiffany says she was surprised by the news of the arrest of martinez, the so-called squirrel. she hopes the arrest leads to finding david's body. >> that's been our call ever since day one, you know, that david would be found and that his remains would be returned so we could, you know, honor him the way that he wanted to be, but as a family be able to find that closure. >> reporter: on monday the mexican navy announced that they had arrested the drug leaders kno

also get data later on this morning in manufacturing, new home sales and earnings from att, boeing, eli lilly, delta and us airways. yesterday, the dow dropping 243 points to close at 13,102. the nasdaq losing 26 points to close at 2,990. the cost of a higher education continues to rise. the college board says instate tuition for a four-year public school rose $400 this fall or about 5% to an average of $8665 a year. that's up modestly from past years. if you include room and board, the total cost averages about $17,860. the price tag for a private school, $39,518. however, only about one-third of the students pay full price, if you factor in student aid, grant, tax credit and scholarships. and paying for that education long after you leave school. guys, before i go, from your favorite east coast refugee, two words, go giants. >> very nice. hampton pierson. thank you kindly. in washington, d.c. this morning. hampton makes an interesting point not just about the giants but about college tuition. we all say it's going up, right? is it really? by the time you pay and you get all those little cre

we've got an oil and gas play, we've got ely lilly, and let's buy some general electric because the stockdown and i think it should be bought. my charitable trust continues to buy it. ted in connecticut, please, ted? >> caller: hey, jim, good afternoon. >> good afternoon to you. >> caller: i'd like to know if i'm diversified. >> okay. >> caller: my stocks are boeing, b.a., american capital agency, agnc, acn, apple, aapl, and energy transfer partners, etp. >> okay. all right. let's go to work. let's tackle these two -- these companies are actionalertsplus.com, they are owned by my charitable trust. boeing reporting a magnificent quarter. this stock should have been up too and energy transfer partners, the worst stock i own for charitable trust. apple, own it, don't trade it. american capital, i like the dividend. we have consulting, mlp, aerospace, tech, mortgage reit, and i think that's terrific and i'm willing to keep it, but remember, energy transfer partners the worst stock that my charitable trust owns. stay with cramer. ♪ want my recipe for healthier hair color? natural instincts! fo

eli lilly after reporting promising alzheimer's data last week today announcing results from a late stage study of its cancer treatment. take a look at a couple other stocks outperforming today as well. bristol-myers and merck trading higher. >>> quick break and we should note that the dow jones industrial average is up 95 points. we're watching that. >>> plus, microsoft moving into the music business in a big way launching a new service. will it be a game changer and can microsoft seriously take on apple? >>> plus, the most powerful person working to get all sides talking to each other to make a deal about the fiscal cliff. >>> and you have never probably even heard of her. >>> as we head out, with the dow up almost 100 points? here are five stocks with price-to-earnings ratios of less than 20 -- ford, seagate, metlife, dell and xerox on the plus side today. [ male announcer ] zeebox is the free app that makes watching tv even better. if your tv were a hot dog zeebox would be some sort of fancy, french mustard. when they magically unite, people would think, "woah, this two dollar hot dog

eli lilly's experimental drug slowed cognitive decline by 34% in patients with mild alzheimer's. morningstar says this is a $20 billion market so a lot of opportunity here. and another reason why investors like pharma. any thoughts? fat dividends. in the current low-rate environment, large-cap pharma yielding roughly 34%, which on average is 2% higher than stocks in the s&p and vastly outperform, the 10-year treasury note. pfizer is a top dividend payer in the group and a likely increase is expected by year end. shares of pfizer have gained 30% since lipitor went off patent last year thanks to recently launched drugs and solid earnings growth. not just pharma is on the move. biotech hitting several all-time highs in the past month. gilleon has a promising hepatitis c drug in development which it acquired in late 2012. m and a has been a major catalyst for biotech stocks. alexion is a player in a niche market which it can effectively dictate pricing which is a huge advantage making it an eye-catching target for large-cap drug firms looking to bill out their portfolio via acquisiti